publication venue for

• ¹⁸F-FDG PET in detection of primary age-related tauopathy (PART) - Is there a role? Insights from an imaging-pathology correlation study 2025
• Discrepancies between CSF biomarker and PET determinations of elevated brain amyloid and their prognostic significance 2025
• Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition 2025
• Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies 2025
• Influence of alpha-synuclein on glucose metabolism in Alzheimer's disease continuum: Analyses of α-synuclein seed amplification assay and FDG-PET 2025
• Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers later in life 2025
• Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia 2025
• Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia 2025
• Sex differences in the executive and behavioral reserve of autosomal dominant frontotemporal dementia 2025
• The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI): Overview of consortium sites and anticipated enrollment 2025
• Advancing specificity in delirium: The delirium subtyping initiative 2024
• Amyloid PET detects the deposition of brain Aβ earlier than CSF fluid biomarkers 2024
• Lewy body dementia: Overcoming barriers and identifying solutions 2024
• Longitudinal associations of reproductive factors and exogeneous estrogens with neuroimaging biomarkers of Alzheimer's disease and cerebrovascular disease 2024
• Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies 2024
• Premenopausal bilateral oophorectomy and brain white matter brain integrity in later-life 2024
• Sex differences in brain atrophy in dementia with Lewy bodies 2024
• White matter changes with cerebrovascular disease and Alzheimer's disease pathologies 2023
• The temporal onset of the core features in dementia with Lewy bodies 2022
• Education differentially contributes to cognitive reserve across racial/ethnic groups 2021
• Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration 2020
• Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint 2020
• Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration 2020
• Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort 2020
• Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases 2020
• Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration 2020
• Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort 2020
• Tau-positron emission tomography correlates with neuropathology findings 2020
• The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology 2020
• Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium 2020
• Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms 2019
• Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome 2019
• Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers 2019
• Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease 2019
• Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative 2019
• The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies 2018
• Understanding the impact of sex and gender in Alzheimer's disease: A call to action 2018
• An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease 2017
• Defining imaging biomarker cut points for brain aging and Alzheimer's disease 2017
• MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies 2016
• Atrial fibrillation, cognitive impairment, and neuroimaging 2016
• Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 2015
• Independent comparison of Cog State computerized testing and a standard cognitive battery with neuroimaging 2014
• Microbleeds in the logopenic variant of primary progressive aphasia 2014